Replicates vs Depth of Sequencing
Let’s start with what we know, RNA-seq offers a number of advantages over microarrays (high-technical reproducibility, dynamic range and discovery of novel transcripts) when you’re [...]
Notes on 23andMe and the FDA
While Cofactor is in the business of helping pharmaceutical, biofuel, and agricultural researchers discover more about the DNA & RNA they study, I wanted to take a moment to discuss an item [...]
